Julie Beeso joins Envision Pharma Group in new Global Director, Professional Development and Engagement role

Horsham, UK, 14 January, 2022

Leading global technology-enabled scientific communications company Envision Pharma Group has appointed Julie Beeso as its Global Director, Professional Development and Engagement.

Having worked for almost 25 years across different medical communications roles in the UK and US, Julie’s extensive expertise will be used to develop, communicate, and execute a comprehensive professional development and talent management strategy for Envision Scientific Solutions (ESS) that supports progressive programs and engagement.

Starting out as a writer, Julie advanced to facilitating the account direction and team leadership for blockbuster launches in a previous role; overseeing new business activities; heading up a company division, and establishing a New York office. Julie joins Envision from Oxford PharmaGenesis where she helped to set up and lead its patient engagement specialty while also focusing on company-wide quality and training activities.

Alongside continuing to teach people how to be the best they can be in a competitive medcomms landscape, Julie’s responsibilities will cover ESS engagement and relations, talent placement and retention, alternative resourcing, and overseeing performance management.

Julie said, “I feel privileged to have the opportunity to work for Envision, whose reputation for integrity and quality – always alongside technological innovation – is second to none. Envision excels through its talented people. The company’s commitment to developing this talent is dynamic and inspiring, and I can’t wait to help take it to the next level!”

Susanne Clark, Global Head, Envision Scientific Services added, “We are thrilled to have Julie Beeso joining the team. With deep market insight and a unique skill set, Julie is ideally placed to meet the needs of a complex and rapidly evolving talent market. At Envision we have grown through continual innovation and improvement, and Julie will begin by scaling up our successful New Medical Writer program and elevating our entry talent offering. We are excited by this new chapter in our talent story.”


-- Ends –

About Envision Pharma Group
Founded in 2001, Envision Pharma Group is a global, innovative technology and scientific communications company serving pharmaceutical, biotechnology, and medical device companies. Envision is a leading provider of evidence-based communication services and industry-leading technology solutions (iEnvision) that have applicability across many areas of medical affairs and related functional responsibility. Envision Pharma Group provides services and technology solutions to more than 90 companies, including all of the top 20 pharmaceutical companies.

Envision has 20 offices: seven in the United Kingdom – Bishop’s Stortford, Glasgow, Horsham, London (Battersea and Hammersmith), Wilmslow, and Alderley Edge; one in Serbia – Subotica; one in Hungary – Szeged; one in Coimbra, Portugal, eight in the United States – Fairfield and Glastonbury, CT, Philadelphia and Wyomissing, PA, Warren, NJ, Boston and Melrose, MA, Powell, OH; and two in the Asia-Pacific region – Tokyo and Sydney. The company employs over 1000 team members, including over 250 highly qualified and experienced in-house medical writers, and 190 technology solutions team members who provide software development and customer support. To find out more, visit www.envisionpharmagroup.com.

For further information:

Marsha Caplin
Global Head of Marketing
Envision Pharma Group
Email: marsha.caplin@envisionpharmagroup.com
Tel: +44 (0)7557 083549